Gordon Bernard

Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of “convalescent plasma” as a treatment for COVID-19. Read More

Vanderbilt University Medical Center is attracting international attention for its proposal to repurpose existing drugs for new uses in ways that can dramatically improve access to medicines by billions of people throughout the world. Read More

The Vanderbilt Institute for Clinical and Translational Research (VICTR), which provides comprehensive support for clinical and translational research at Vanderbilt University Medical Center (VUMC), has been named Administrative Coordinating Center (ACC) of a national effort to streamline the research response to life-threatening lung and heart problems caused by COVID-19. Read More

The John D. and Catherine T. MacArthur Foundation today unveiled a grant proposal from Vanderbilt University Medical Center (VUMC) as one of the highest-scoring proposals, designated as the “Top 100,” in its 100&Change competition for a single $100 million grant to help solve one of the world’s most critical societal challenges. Read More

IBM Watson Health has announced plans to make a 10-year, $50 million investment in joint research collaborations with Vanderbilt University Medical Center and Brigham and Women’s Hospital to advance the science of artificial intelligence and its application to major public health issues. Read More

VISE celebrated its opening of dedicated space in Medical Center North Dec. 12 with a technology showcase of more than two dozen cross-disciplinary collaborations advancing healthcare techniques from the lab to patients. Read More

A clinical trial of an intervention for sepsis in patients in Zambia, led by Vanderbilt investigators, topped the list of 2017 trials featured by the website The Bottom Line. Read More

Fourteen years after it was launched, REDCap, Vanderbilt University’s research data management tool, has transformed clinical and translational studies around the globe. Read More

Clinical and translational research at Vanderbilt University Medical Center (VUMC) is thriving. Read More

Vanderbilt University Medical Center (VUMC) has competed successfully for a second renewal of its Clinical and Translational Science Award (CTSA) by the National Institutes of Health (NIH). Read More

Communication and collaboration were major themes of the inaugural Research Enterprise Forum sponsored jointly by Vanderbilt University Medical Center (VUMC) and Vanderbilt University School of Medicine (VUSM) Feb. 3 in Light Hall. Read More

Gordon Bernard, M.D., Executive Vice President for Research at Vanderbilt University Medical Center (VUMC), will receive the American College of Critical Care Medicine’s highest honor, the Distinguished Investigator Award, during the Society of Critical Care Medicine’s (SCCM) 46th Critical Care Congress in Honolulu in January, 2017. Read More

Researchers at Vanderbilt University Medical Center and Duke Clinical Research Institute have received a major federal grant to study how multisite clinical trials of new drugs and therapies in children and adults can be conducted more rapidly and efficiently. Read More

Vanderbilt University Medical Center has entered into a strategic research agreement with Celgene Corporation, a biopharmaceutical company based in Summit, New Jersey. Read More

Ten members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science. Read More

Two physician-scientist leaders at Vanderbilt University Medical Center were honored last week with newly created awards for helping to build and nurture Vanderbilt’s vibrant culture of clinical and translational research. Read More

The Vanderbilt Institute for Clinical and Translational Research (VICTR) is partnering with a public charity, Cures Within Reach, to encourage “rediscovery research,” the “repurposing” of already approved medical treatments to other conditions or diseases for which there are no “universally” effective therapies. Read More

Tina Hartert, M.D., MPH, professor of Medicine in the Division of Allergy, Pulmonary and Critical Care Medicine, has been named assistant vice chancellor for Translational Science. Read More

The Vanderbilt community is invited to attend the 12th annual Research Retreat, a showcase of cutting-edge biomedical science by Vanderbilt faculty members and trainees. Read More

VUMC researchers have reported promising results in using oral antimycobacterial therapy to treat chronic cutaneous sarcoidosis, considered by clinicians a difficult illness to effectively control. Read More